Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Nov;154(11):2324-2334.
doi: 10.1016/j.pain.2013.06.035.

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations

Alec B O'Connor  1 , Dennis C Turk, Robert H Dworkin, Nathaniel P Katz, Robert Colucci, Jennifer A Haythornthwaite, Michael Klein, Charles O'Brien, Kelly Posner, Bob A Rappaport, Gary Reisfield, Edgar H Adams, Robert L Balster, George E Bigelow, Laurie B Burke, Sandra D Comer, Edward Cone, Penney Cowan, Richard A Denisco, John T Farrar, Richard W Foltin, David J Haddox, Sharon Hertz, Gary W Jay, Roderick Junor, Ernest A Kopecky, Deborah B Leiderman, Michael P McDermott, Pamela P Palmer, Srinivasa N Raja, Christine Rauschkolb, Michael C Rowbotham, Cristina Sampaio, Beatrice Setnik, Shannon M Smith, Marta Sokolowska, Joseph W Stauffer, Sharon L Walsh, James P Zacny
Affiliations
Review

Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations

Alec B O'Connor et al. Pain. 2013 Nov.

Abstract

Assessing and mitigating the abuse liability (AL) of analgesics is an urgent clinical and societal problem. Analgesics have traditionally been assessed in randomized clinical trials (RCTs) designed to demonstrate analgesic efficacy relative to placebo or an active comparator. In these trials, rigorous, prospectively designed assessment for AL is generally not performed. The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) convened a consensus meeting to review the available evidence and discuss methods for improving the assessment of the AL of analgesics in clinical trials in patients with pain. Recommendations for improved assessment include: (1) performing trials that include individuals with diverse risks of abuse; (2) improving the assessment of AL in clinical trials (eg, training study personnel in the principles of abuse and addiction behaviors, designing the trial to assess AL outcomes as primary or secondary outcome measures depending on the trial objectives); (3) performing standardized assessment of outcomes, including targeted observations by study personnel and using structured adverse events query forms that ask all subjects specifically for certain symptoms (such as euphoria and craving); and (4) collecting detailed information about events of potential concern (eg, unexpected urine drug testing results, loss of study medication, and dropping out of the trial). The authors also propose a research agenda for improving the assessment of AL in future trials.

Keywords: Abuse; Abuse liability; Clinical trial; Opioids; Prescription drug abuse; Risk of abuse; Study design.

PubMed Disclaimer

Comment in

References

    1. Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE. A comparison of the AL of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006;31:465-476.
    1. Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, Noe C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004;27:440-459.
    1. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287-293.
    1. Banta-Green CJ, Merrill JO, Doyle SR, Boudreay DM, Calsyn DA. Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend. 2009;104:43-49.
    1. Becker WC, Fraenkel L, Edelman EJ, Hold SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. PAIN® 2013;154:905–16.